Cargando…
Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report
Autores principales: | Giarratano, A, Cuccio, G, Mangione, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332953/ http://dx.doi.org/10.1186/cc749 |
Ejemplares similares
-
Association of Deficiency of Coagulation Factors (Prs, Prc, ATIII) and FVL Positivity with Preeclampsia and/or Eclampsia in Pregnant Women
por: Dehkordi, Maryam Al-e-Rasul, et al.
Publicado: (2014) -
Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience
por: Buscemi, C, et al.
Publicado: (2008) -
Control of DIC after administration of ATIII in ICU septic patients
por: Vasiliagou, S, et al.
Publicado: (2001) -
Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000) -
Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)